COMP <GO>
NUTX vs RDWR // EV/EBITDA & P/E VALUATION
Nutex Health Inc. (NASDAQ) VS. Radware Ltd. (NASDAQ) • 15-METRIC TALLY: NUTX 8
— RDWR 3
▲ EV/EBITDA & P/E VALUATION LEADER: NUTX
LAST: $210.10 (-1.19%) • MKT CAP: $1.44B
valuation
4.6x
LAST: $36.64 (-1.40%) • MKT CAP: $1.55B
valuation
77.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NUTX VS. RDWR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NUTX | RDWR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 50.80% | 80.70% | -29.90 | RDWR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | 3.70% | +81.30 | NUTX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 4.6x | 77.4x | -72.80 | NUTX | /valuation <GO> |
| Free Cash Flow Yield | 17.07% | 2.68% | +14.39 | NUTX | /fcf-yield <GO> |
| Operating Margin | 31.50% | 3.80% | +27.70 | NUTX | /operating-margins <GO> |
| Net Profit Margin | 8.10% | 6.70% | +1.40 | NUTX | /net-margins <GO> |
| Revenue Growth (YoY) | 82.40% | 9.80% | +72.60 | NUTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.75 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | NUTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.7 | 62.3 | -15.57 | RDWR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.1x | 71.1x | -54.00 | NUTX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.44B | $1.55B | -$111.4M | RDWR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NUTX REV | RDWR REV | NUTX GROSS % | RDWR GROSS % | NUTX FCF | RDWR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $875.3M | $301.9M | 50.8% | 80.7% | $245.6M | $41.6M |
| FY 2024 | $479.9M | $274.9M | 40.9% | 80.6% | $20.8M | $66.3M |
| FY 2023 | $247.6M | $261.3M | — | — | $1.3M | -$3.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NUTX // BETA —
RDWR // BETA —